|
Volumn 19, Issue 6, 1999, Pages 581-588
|
Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
LYSINE ACETYLSALICYLATE;
SUMATRIPTAN;
ADULT;
AGED;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MIGRAINE;
MULTICENTER STUDY;
NAUSEA;
PAIN ASSESSMENT;
PHOTOPHOBIA;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RECURRENT DISEASE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
VERTIGO;
VISUAL DISORDER;
VOMITING;
ADULT;
ANALGESICS;
ASPIRIN;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
LYSINE;
MALE;
MIDDLE AGED;
MIGRAINE DISORDERS;
RECURRENCE;
SUMATRIPTAN;
TREATMENT OUTCOME;
VASOCONSTRICTOR AGENTS;
|
EID: 0032815672
PISSN: 03331024
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-2982.1999.019006581.x Document Type: Article |
Times cited : (132)
|
References (8)
|